Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Evaluation of Pharmacokinetics, Efficacy and Safety of a New Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency

Claudia Djambas Khayat, Heike Boehm, Silke Aigner, Salomon Abraha, Fabian Bohlaender, Joerg Schuettrumpf

Blood (2024) 144 (Supplement 1): 1221.

https://doi.org/10.1182/blood-2024-198116

Published: 2024

Journal Articles

Mesenchymal Stromal Cells Suppress T-and B-Cells via Galectin-9 in a Donor Dependent Manner

Christopher Ungerer, Patricia Quade-Lyssy, Reinhard Henschler, Erhard Seifried, MD, PhD, Heinfried Radeke, Joerg Schuettrumpf, MD

Blood (2012) 120 (21): 1248.

https://doi.org/10.1182/blood.V120.21.1248.1248

Published: 2012

Journal Articles

Protease−Activated Receptor 2 (PAR−2) as a Novel Target To Prevent Inhibitor Formation to FIX.

Stefano Baila, Christian Furlan Freguia, Nicholas Iacobelli, Danielle Dunn, Joerg Schuettrumpf, Federico Mingozzi, Patricia Andrade-Gordon, Valder R. Arruda

Blood (2006) 108 (11): 763.

https://doi.org/10.1182/blood.V108.11.763.763

Published: 2006

Journal Articles

Differences in the Anticoagulant Activity of Murine and Human Activated Protein C (APC) in Mouse Thrombosis Models.

Christian Furlan Freguia, Joerg Schuettrumpf, Stefano Baila, Alexander Schlachterman, Jianxang Zou, Shangzhen Zhou, Valder R. Arruda

Blood (2006) 108 (11): 1471.

https://doi.org/10.1182/blood.V108.11.1471.1471

Published: 2006

Journal Articles

Assessing the Role of Continuous Activated Protein C (APC) Expression in Murine Thrombosis Models.

Joerg Schuettrumpf, MD, Alexander Schlachterman, Jianxiang Zou, PhD, Christian Furlan Freguia, Stefano Baila, Valder R. Arruda, MD

Blood (2005) 106 (11): 1030.

https://doi.org/10.1182/blood.V106.11.1030.1030

Published: 2005

Journal Articles

Co-Inheritance of FV Leiden and High Levels of FIX Results in Novel Models for Thrombophilia and Spontaneous Fetal Loss.

Christian Furlan Freguia, Joerg Schuettrumpf, Stefano Baila, Jianhua Liu, Ralph Bunte, Rodney M. Camire, Valder R. Arruda

Blood (2005) 106 (11): 1946.

https://doi.org/10.1182/blood.V106.11.1946.1946

Published: 2005

Journal Articles

Factor IX variants improve gene therapy efficacy for hemophilia B

Joerg Schuettrumpf, Roland W. Herzog, Alexander Schlachterman, Antje Kaufhold, Darrel W. Stafford, Valder R. Arruda

Blood (2005) 105 (6): 2316–2323.

https://doi.org/10.1182/blood-2004-08-2990

Published: 2005

Journal Articles

A Novel Method of Regional Intravenous Delivery of AAV Vector to Skeletal Muscle Results in Correction of Canine Hemophilia B Phenotype.

Valder R. Arruda, MD, Hansell H. Stedman, MD, Joerg Schuettrumpf, MD, Haiyan Jiang, PhD, Glenn Pierce, MD, Timothy C. Nichols, MD, Katherine A. High, MD

Blood (2004) 104 (11): 3179.

https://doi.org/10.1182/blood.V104.11.3179.3179

Published: 2004

Journal Articles

A Novel Role of Coagulation Proteases on Viral-Based Gene Transfer Efficacy.

Joerg Schuettrumpf, MD, Jianxiang Zou, PhD, Shin Jen Tai, Alexander Schlachterman, Kian Tian, Shyrie Edmonson, Jianhua Liu, Patricia Andrade-Gordon, MD, Katherine High, MD, Valder Arruda, MD

Blood (2004) 104 (11): 691.

https://doi.org/10.1182/blood.V104.11.691.691

Published: 2004

Journal Articles

Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene

Denise E. Sabatino, Elina Armstrong, Shyrie Edmonson, Yi-Lin Liu, Marc Pleimes, Joerg Schuettrumpf, Julie Fitzgerald, Roland W. Herzog, Valder R. Arruda, Katherine A. High

Blood (2004) 104 (9): 2767–2774.

https://doi.org/10.1182/blood-2004-03-1028

Published: 2004

Journal Articles

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1

Valder R. Arruda, Joerg Schuettrumpf, Roland W. Herzog, Timothy C. Nichols, Nancy Robinson, Yasmin Lotfi, Federico Mingozzi, Weidong Xiao, Linda B. Couto, Katherine A. High

Blood (2004) 103 (1): 85–92.

https://doi.org/10.1182/blood-2003-05-1446

Published: 2004

NARROW

Evaluation of Pharmacokinetics, Efficacy and Safety of a New Human Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency

Mesenchymal Stromal Cells Suppress T-and B-Cells via Galectin-9 in a Donor Dependent Manner

Protease−Activated Receptor 2 (PAR−2) as a Novel Target To Prevent Inhibitor Formation to FIX.

Differences in the Anticoagulant Activity of Murine and Human Activated Protein C (APC) in Mouse Thrombosis Models.

Assessing the Role of Continuous Activated Protein C (APC) Expression in Murine Thrombosis Models.

Co-Inheritance of FV Leiden and High Levels of FIX Results in Novel Models for Thrombophilia and Spontaneous Fetal Loss.

Factor IX variants improve gene therapy efficacy for hemophilia B

A Novel Method of Regional Intravenous Delivery of AAV Vector to Skeletal Muscle Results in Correction of Canine Hemophilia B Phenotype.

A Novel Role of Coagulation Proteases on Viral-Based Gene Transfer Efficacy.

Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only